Suppressing fatty acid synthase by type I interferon and chemical inhibitors as a broad spectrum anti-viral strategy against SARS-CoV-2

[1]  G. Cheng,et al.  Protease cleavage of RNF20 facilitates coronavirus replication via stabilization of SREBP1 , 2021, Proceedings of the National Academy of Sciences.

[2]  Zhuanchang Wu,et al.  Palmitoylation of SARS-CoV-2 S protein is essential for viral infectivity , 2021, Signal Transduction and Targeted Therapy.

[3]  A. Brenner,et al.  First-in-human study of the safety, pharmacokinetics, and pharmacodynamics of first-in-class fatty acid synthase inhibitor TVB-2640 alone and with a taxane in advanced tumors , 2021, EClinicalMedicine.

[4]  L. Henderson,et al.  American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS–CoV‐2 and Hyperinflammation in Pediatric COVID‐19: Version 2 , 2020, Arthritis & rheumatology.

[5]  V. Thiel,et al.  Coronavirus biology and replication: implications for SARS-CoV-2 , 2020, Nature Reviews Microbiology.

[6]  G. Cheng,et al.  25-Hydroxycholesterol is a potent SARS-CoV-2 inhibitor , 2020, Cell Research.

[7]  Shinji Makino,et al.  An Infectious cDNA Clone of SARS-CoV-2 , 2020, Cell Host & Microbe.

[8]  Dong Yang,et al.  SREBP-dependent lipidomic reprogramming as a broad-spectrum antiviral target , 2019, Nature Communications.

[9]  Zhènglì Shí,et al.  Origin and evolution of pathogenic coronaviruses , 2018, Nature Reviews Microbiology.

[10]  L. Abrami,et al.  Palmitoylation mediates membrane association of hepatitis E virus ORF3 protein and is required for infectious particle secretion , 2018, PLoS pathogens.

[11]  Leiliang Zhang,et al.  Fatty Acid Synthase Promotes the Palmitoylation of Chikungunya Virus nsP1 , 2018, Journal of Virology.

[12]  K. Kwiatkowska,et al.  Protein Palmitoylation and Its Role in Bacterial and Viral Infections , 2018, Front. Immunol..

[13]  B. Sitek,et al.  Deciphering of the Human Interferon-Regulated Proteome by Mass Spectrometry-Based Quantitative Analysis Reveals Extent and Dynamics of Protein Induction and Repression , 2017, Front. Immunol..

[14]  Y. Li,et al.  Altered Lipid Metabolism in Recovered SARS Patients Twelve Years after Infection , 2017, Scientific Reports.

[15]  Ping Liu,et al.  25‐Hydroxycholesterol Protects Host against Zika Virus Infection and Its Associated Microcephaly in a Mouse Model , 2017, Immunity.

[16]  Tracie Delgado,et al.  Glycolysis, Glutaminolysis, and Fatty Acid Synthesis Are Required for Distinct Stages of Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication , 2017, Journal of Virology.

[17]  S. Yoksan,et al.  Involvement of fatty acid synthase in dengue virus infection , 2017, Virology Journal.

[18]  D. Ory,et al.  Fatty acid synthesis configures the plasma membrane for inflammation in diabetes , 2016, Nature.

[19]  A. Valenzuela-Fernández,et al.  Membrane dynamics associated with viral infection , 2016, Reviews in medical virology.

[20]  Jason Mercer,et al.  Lipid interactions during virus entry and infection , 2014, Cellular microbiology.

[21]  Ren-Jye Lin,et al.  Rab18 Facilitates Dengue Virus Infection by Targeting Fatty Acid Synthase to Sites of Viral Replication , 2014, Journal of Virology.

[22]  Y. Sasai,et al.  Self-organization of axial polarity, inside-out layer pattern, and species-specific progenitor dynamics in human ES cell–derived neocortex , 2013, Proceedings of the National Academy of Sciences.

[23]  A. Lever,et al.  Inhibition of rotavirus replication by downregulation of fatty acid synthesis. , 2013, The Journal of general virology.

[24]  N. Sakamoto,et al.  Hepatitis C Virus Replication Is Modulated by the Interaction of Nonstructural Protein NS5B and Fatty Acid Synthase , 2013, Journal of Virology.

[25]  Zhijian J. Chen,et al.  Cyclic GMP-AMP Synthase Is a Cytosolic DNA Sensor That Activates the Type I Interferon Pathway , 2013, Science.

[26]  G. Cheng,et al.  Interferon-inducible cholesterol-25-hydroxylase broadly inhibits viral entry by production of 25-hydroxycholesterol. , 2013, Immunity.

[27]  G. Cheng,et al.  Poly I:C Enhances Susceptibility to Secondary Pulmonary Infections by Gram-Positive Bacteria , 2012, PloS one.

[28]  Tracie Delgado,et al.  Global Metabolic Profiling of Infection by an Oncogenic Virus: KSHV Induces and Requires Lipogenesis for Survival of Latent Infection , 2012, PLoS pathogens.

[29]  J. Rathmell,et al.  Dysregulation of fatty acid synthesis and glycolysis in non-Hodgkin lymphoma , 2012, Proceedings of the National Academy of Sciences.

[30]  G. Cheng,et al.  Systematic identification of type I and type II interferon-induced antiviral factors , 2012, Proceedings of the National Academy of Sciences.

[31]  J. Saiz,et al.  West Nile Virus Replication Requires Fatty Acid Synthesis but Is Independent on Phosphatidylinositol-4-Phosphate Lipids , 2011, PloS one.

[32]  C. Zheng,et al.  Cloning of the herpes simplex virus type 1 genome as a novel luciferase-tagged infectious bacterial artificial chromosome , 2011, Archives of Virology.

[33]  Sarah L. Grady,et al.  Divergent Effects of Human Cytomegalovirus and Herpes Simplex Virus-1 on Cellular Metabolism , 2011, PLoS pathogens.

[34]  N. Heaton,et al.  Multifaceted roles for lipids in viral infection , 2011, Trends in Microbiology.

[35]  Christopher T. Jones,et al.  A diverse array of gene products are effectors of the type I interferon antiviral response , 2011, Nature.

[36]  Nathaniel J. Moorman,et al.  Human Cytomegalovirus Induces the Activity and Expression of Acetyl-Coenzyme A Carboxylase, a Fatty Acid Biosynthetic Enzyme Whose Inhibition Attenuates Viral Replication , 2011, Journal of Virology.

[37]  P. R. Deepa,et al.  Chemical inhibition of fatty acid synthase: molecular docking analysis and biochemical validation in ocular cancer cells , 2010, Journal of ocular biology, diseases, and informatics.

[38]  N. Heaton,et al.  Dengue virus nonstructural protein 3 redistributes fatty acid synthase to sites of viral replication and increases cellular fatty acid synthesis , 2010, Proceedings of the National Academy of Sciences.

[39]  J. Menéndez,et al.  Infection with HIV and HCV enhances the release of fatty acid synthase into circulation: evidence for a novel indicator of viral infection , 2010, BMC gastroenterology.

[40]  N. Friedman,et al.  Comprehensive comparative analysis of strand-specific RNA sequencing methods , 2010, Nature Methods.

[41]  S. Akira,et al.  The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors , 2010, Nature Immunology.

[42]  Benhur Lee,et al.  A catalytically and genetically optimized β-lactamase-matrix based assay for sensitive, specific, and higher throughput analysis of native henipavirus entry characteristics , 2009, Virology Journal.

[43]  S. Salzberg,et al.  TopHat: discovering splice junctions with RNA-Seq , 2009, Bioinform..

[44]  Simon C Watkins,et al.  Fatty acid synthase is up‐regulated during hepatitis C virus infection and regulates hepatitis C virus entry and production , 2008, Hepatology.

[45]  G. Barber,et al.  STING an Endoplasmic Reticulum Adaptor that Facilitates Innate Immune Signaling , 2008, Nature.

[46]  Xiao-Jiang Feng,et al.  Systems-level metabolic flux profiling identifies fatty acid synthesis as a target for antiviral therapy , 2008, Nature Biotechnology.

[47]  A. Shavinskaya,et al.  The Lipid Droplet Binding Domain of Hepatitis C Virus Core Protein Is a Major Determinant for Efficient Virus Assembly* , 2007, Journal of Biological Chemistry.

[48]  M. Chelbi-alix,et al.  Interferon, a growing cytokine family: 50 years of interferon research. , 2007, Biochimie.

[49]  Shizuo Akira,et al.  Antiviral signaling through pattern recognition receptors. , 2006, Journal of biochemistry.

[50]  Michael Karin,et al.  Intracellular pattern recognition receptors in the host response , 2006, Nature.

[51]  W. Tian.  Inhibition of fatty acid synthase by polyphenols. , 2006, Current medicinal chemistry.

[52]  Zhijian J. Chen,et al.  Antiviral innate immunity pathways , 2006, Cell Research.

[53]  Shizuo Akira,et al.  Toll-like receptor signalling , 2004, Nature Reviews Immunology.

[54]  M. J. Cody,et al.  TLR4, but not TLR2, mediates IFN-β–induced STAT1α/β-dependent gene expression in macrophages , 2002, Nature Immunology.

[55]  E. Fish,et al.  The interferon-inducible Stat2:Stat1 heterodimer preferentially binds in vitro to a consensus element found in the promoters of a subset of interferon-stimulated genes. , 2001, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[56]  C. Townsend,et al.  Synthesis and antitumor activity of an inhibitor of fatty acid synthase , 2000 .

[57]  B. Williams,et al.  Identification of genes differentially regulated by interferon α, β, or γ using oligonucleotide arrays , 1998 .

[58]  A. Sanchez,et al.  A system for functional analysis of Ebola virus glycoprotein. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[59]  G. Sen,et al.  Interferons and viral infections , 2009, BioFactors.

[60]  S. Akira,et al.  Pathogen recognition by innate immunity and its signaling , 2009, Proceedings of the Japan Academy. Series B, Physical and biological sciences.

[61]  H. Bluyssen,et al.  STAT activation and differential complex formation dictate selectivity of interferon responses. , 2007, Acta biochimica Polonica.

[62]  C. Janeway,et al.  Innate immune recognition. , 2002, Annual review of immunology.

[63]  C. Le Page,et al.  Interferon activation and innate immunity. , 2000, Reviews in immunogenetics.